Dermapharm Holding SE provided earnings guidance for the year 2020. The management board expects further Group growth in fiscal year 2020 compared to the previous year. Based on volume gains and successful launches of products the company has developed itself, the management board expects organic growth in Group sales in the upper single-digit percentage range.